Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
Identifieur interne : 001016 ( Main/Exploration ); précédent : 001015; suivant : 001017Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
Auteurs : Camille Roubille [Canada] ; Boulos Haraoui [Canada]Source :
- Seminars in arthritis and rheumatism [ 1532-866X ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
- effets indésirables : Antirhumatismaux, Facteurs biologiques.
- traitement médicamenteux : Polyarthrite rhumatoïde.
- usage thérapeutique : Antirhumatismaux, Facteurs biologiques.
- Humains, Pneumopathies interstitielles.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antirheumatic Agents, Biological Factors.
- chemical , therapeutic use : Antirheumatic Agents, Biological Factors.
- chemically induced : Lung Diseases, Interstitial.
- drug therapy : Arthritis, Rheumatoid.
- Humans.
Abstract
To review published cases of induced or exacerbated interstitial lung disease (ILD) in rheumatoid arthritis (RA) associated with non-biologic disease-modifying antirheumatic drugs (nbDMARDs) and biologics and to discuss clinical implications in daily practice.
DOI: 10.1016/j.semarthrit.2013.09.005
PubMed: 24231065
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000315
- to stream PubMed, to step Curation: 000315
- to stream PubMed, to step Checkpoint: 000285
- to stream Ncbi, to step Merge: 000226
- to stream Ncbi, to step Curation: 000226
- to stream Ncbi, to step Checkpoint: 000226
- to stream Main, to step Merge: 001017
- to stream Main, to step Curation: 001016
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.</title><author><name sortKey="Roubille, Camille" sort="Roubille, Camille" uniqKey="Roubille C" first="Camille" last="Roubille">Camille Roubille</name><affiliation wicri:level="1"><nlm:affiliation>Osteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Notre-Dame Hospital, Montreal, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Osteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Notre-Dame Hospital, Montreal, Quebec</wicri:regionArea><wicri:noRegion>Quebec</wicri:noRegion></affiliation></author><author><name sortKey="Haraoui, Boulos" sort="Haraoui, Boulos" uniqKey="Haraoui B" first="Boulos" last="Haraoui">Boulos Haraoui</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, Rheumatic Disease Unit, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada; Institut de rhumatologie de Montréal, 1551 Ontario St East, Montreal, Quebec, Canada H2L 1S6. Electronic address: boulos.haraoui@ssss.gouv.qc.ca.</nlm:affiliation><country>Canada</country><wicri:regionArea>Department of Medicine, Rheumatic Disease Unit, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada; Institut de rhumatologie de Montréal, 1551 Ontario St East, Montreal, Quebec</wicri:regionArea><wicri:noRegion>Quebec</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24231065</idno><idno type="pmid">24231065</idno><idno type="doi">10.1016/j.semarthrit.2013.09.005</idno><idno type="wicri:Area/PubMed/Corpus">000315</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000315</idno><idno type="wicri:Area/PubMed/Curation">000315</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000315</idno><idno type="wicri:Area/PubMed/Checkpoint">000285</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000285</idno><idno type="wicri:Area/Ncbi/Merge">000226</idno><idno type="wicri:Area/Ncbi/Curation">000226</idno><idno type="wicri:Area/Ncbi/Checkpoint">000226</idno><idno type="wicri:Area/Main/Merge">001017</idno><idno type="wicri:Area/Main/Curation">001016</idno><idno type="wicri:Area/Main/Exploration">001016</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.</title><author><name sortKey="Roubille, Camille" sort="Roubille, Camille" uniqKey="Roubille C" first="Camille" last="Roubille">Camille Roubille</name><affiliation wicri:level="1"><nlm:affiliation>Osteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Notre-Dame Hospital, Montreal, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Osteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Notre-Dame Hospital, Montreal, Quebec</wicri:regionArea><wicri:noRegion>Quebec</wicri:noRegion></affiliation></author><author><name sortKey="Haraoui, Boulos" sort="Haraoui, Boulos" uniqKey="Haraoui B" first="Boulos" last="Haraoui">Boulos Haraoui</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, Rheumatic Disease Unit, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada; Institut de rhumatologie de Montréal, 1551 Ontario St East, Montreal, Quebec, Canada H2L 1S6. Electronic address: boulos.haraoui@ssss.gouv.qc.ca.</nlm:affiliation><country>Canada</country><wicri:regionArea>Department of Medicine, Rheumatic Disease Unit, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada; Institut de rhumatologie de Montréal, 1551 Ontario St East, Montreal, Quebec</wicri:regionArea><wicri:noRegion>Quebec</wicri:noRegion></affiliation></author></analytic><series><title level="j">Seminars in arthritis and rheumatism</title><idno type="eISSN">1532-866X</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antirheumatic Agents (adverse effects)</term><term>Antirheumatic Agents (therapeutic use)</term><term>Arthritis, Rheumatoid (drug therapy)</term><term>Biological Factors (adverse effects)</term><term>Biological Factors (therapeutic use)</term><term>Humans</term><term>Lung Diseases, Interstitial (chemically induced)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antirhumatismaux (effets indésirables)</term><term>Antirhumatismaux (usage thérapeutique)</term><term>Facteurs biologiques (effets indésirables)</term><term>Facteurs biologiques (usage thérapeutique)</term><term>Humains</term><term>Pneumopathies interstitielles ()</term><term>Polyarthrite rhumatoïde (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antirheumatic Agents</term><term>Biological Factors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antirheumatic Agents</term><term>Biological Factors</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Lung Diseases, Interstitial</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antirhumatismaux</term><term>Facteurs biologiques</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Polyarthrite rhumatoïde</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirhumatismaux</term><term>Facteurs biologiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Pneumopathies interstitielles</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To review published cases of induced or exacerbated interstitial lung disease (ILD) in rheumatoid arthritis (RA) associated with non-biologic disease-modifying antirheumatic drugs (nbDMARDs) and biologics and to discuss clinical implications in daily practice.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Roubille, Camille" sort="Roubille, Camille" uniqKey="Roubille C" first="Camille" last="Roubille">Camille Roubille</name></noRegion><name sortKey="Haraoui, Boulos" sort="Haraoui, Boulos" uniqKey="Haraoui B" first="Boulos" last="Haraoui">Boulos Haraoui</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001016 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001016 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24231065
|texte= Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24231065" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |